We are live on ! Find out more
CXAC.WS

C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS

Delisted

CXAC.WS was delisted on the 11th of October, 2023.

39 hedge funds and large institutions have $7.81M invested in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

3% less funds holding

Funds holding: 4039 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

21% less capital invested

Capital invested by funds: $9.89M → $7.81M (-$2.08M)

Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
5
Reduced
5
Closed
7
Calls
$1.55M
Puts
Net Calls
+$1.55M
Net Calls Change
-$29K

CXAC.WS Hedge Fund Activity: Q3 2022 in Review

39 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) for Q3 2022, worth a combined $7.81M — down 21% from $9.89M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CXAC.WS and 6 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.

The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $57.9K. The largest seller was Mangrove Partners, exiting entirely with an estimated $105K sold.

  • 39 institutional investors held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) as of Q3 2022, down from 40 in Q2 2022.
  • Funds reported $7.81M of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share stock for Q3 2022, down 21% quarter-over-quarter.
  • 6 funds opened new C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share positions in Q3 2022 and 7 closed out, a net change of -1 holder.
  • The largest C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share buyer in Q3 2022 was Castle Creek Arbitrage, an estimated $57.9K added.
  • The largest C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share seller in Q3 2022 was Mangrove Partners, an estimated $105K sold.

Based on aggregated 13F filings for Q3 2022.